Strategic Initiative

Slingshot members are tracking this corporate initiative:

Teva (TEVA) and Regeneron (REGN) Agree to Global Commercialization and Development Deal for REGN's Fasinumab in Chronic Lower Back Pain

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks


Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Sep 20, 2016
Projected Implementation:
Q4, 2016
Relevance Tracked Until:
Q4, 2018
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Global Partnership, Commercialization, Development, Fasinumab, Chronic Lower Back Pain